High Dose per Fraction, Hypofractionated Treatment Effects in the Clinic (HyTEC): an overview

Tolerance of normal tissue to therapeutic irradiation

Emami, B., Lyman, J., Brown, A., Cola, L., Goitein, M., Munzenrider, J. E., Shank, B., Solin, L. J., & Wesson, M. (1991) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(91)90171-y · Cited by 4,488 · see citing works

Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer

Timmerman, R. D. (2010) · JAMA · doi:10.1001/jama.2010.261 · Cited by 2,536 · see citing works

Stereotactic body radiation therapy: The report of AAPM Task Group 101

Benedict, S., Yenice, K. M., Followill, D. S., Galvin, J. M., Hinson, W., Kavanagh, B. D., Keall, P., Lovelock, M., Meeks, S. L., Papiez, L. S., et al. (2010) · Medical Physics · doi:10.1118/1.3438081 · Cited by 2,223 · see citing works

Use of Normal Tissue Complication Probability Models in the Clinic

Marks, L. B., Yorke, E. D., Jackson, A., Ten Haken, R. K., Constine, L. S., Eisbruch, A., Bentzen, S. M., Nam, J., & Deasy, J. O. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.07.1754 · Cited by 1,826 · see citing works

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials

Chang, J. Y., Senan, S., Paul, M. A., Mehran, R. J., Louie, A. V., Balter, P., Groen, H. J. M., McRae, S. E., Widder, J., Feng, L., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)70168-3 · Cited by 1,462 · see citing works

Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer

Donovan, J., Hamdy, F. C., Lane, J. A., Mason, M. D., Metcalfe, C. D., Walsh, E. I., Blazeby, J. M., Peters, T. J., Holding, P., Bonnington, S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1606221 · Cited by 1,344 · see citing works

Fitting of normal tissue tolerance data to an analytic function

Burman, C. M., Kutcher, G. J., Emami, B., & Goitein, M. (1991) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(91)90172-z · Cited by 1,251 · see citing works

Clinical Radiation Pathology

Andrews, J. R., Rubin, P., & Casarett, G. W. (1968) · Radiation Research · doi:10.2307/3572601 · Cited by 916 · see citing works

TEXTBOOK OF RADIOTHERAPY

Fletcher, G. H. (1967) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196704000-00014 · Cited by 868 · see citing works

An Overview of Hypofractionation and Introduction to This Issue of Seminars in Radiation Oncology

Timmerman, R. D. (2008) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2008.04.001 · Cited by 479 · see citing works

Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trials

King, C. R., Freeman, D. E., Kaplan, I., et al. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.08.030 · Cited by 456 · see citing works

A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927)

Videtic, G. M. M., Hu, C., Singh, A. K., Chang, J. Y., Parker, W., Olivier, K. R., Schild, S. E., Komaki, R. K., Urbanic, J. J., & Choy, H. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.07.2260 · Cited by 416 · see citing works

Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain

Milano, M. T., Grimm, J., Niemierko, A., et al. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.08.013 · Cited by 404 · see citing works

RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1-3) spine metastases: Phase 2 results

Ryu, S., Pugh, S. L., Gerszten, P. C., et al. (2013) · Practical Radiation Oncology · doi:10.1016/j.prro.2013.05.001 · Cited by 263 · see citing works

Stereotactic Body Radiation Therapy

Chang, B. K., & Timmerman, R. D. (2007) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3180ca7cb1 · Cited by 240 · see citing works

Local Control After Stereotactic Body Radiation Therapy for Liver Tumors

Ohri, N., Tomé, W. A., Romero, A. M., Miften, M. M., Haken, R. K. T., Dawson, L. A., Grimm, J., Yorke, E. D., & Jackson, A. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.12.288 · Cited by 232 · see citing works

Improved methodology for analyzing local and distant recurrence.

Gelman, R. S., Gelber, R. D., Henderson, I. C., Coleman, C. N., & Harris, J. R. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.3.548 · Cited by 226 · see citing works

American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology

Mayo, C. S., Moran, J. M., Bosch, W. R., Xiao, Y., McNutt, T., Popple, R. A., Michalski, J. M., Feng, M. U.-S., Marks, L. B., Fuller, C. D., et al. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.12.013 · Cited by 213 · see citing works

The Lessons of QUANTEC: Recommendations for Reporting and Gathering Data on Dose–Volume Dependencies of Treatment Outcome

Jackson, A., Marks, L. B., Bentzen, S. M., Eisbruch, A., Yorke, E. D., Haken, R. K. T., Constine, L. S., & Deasy, J. O. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.08.074 · Cited by 203 · see citing works

Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas

Katz, M. H. G., Ou, F., Herman, J. M., Ahmad, S. A., Wolpin, B. W., Marsh, R., Behr, S. C., Shi, Q., Chuong, M. D., Schwartz, L. H., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3441-z · Cited by 184 · see citing works

Simple Factors Associated With Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy of the Thorax: A Pooled Analysis of 88 Studies

Zhao, J., Yorke, E. D., Li, L., et al. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.03.024 · Cited by 179 · see citing works

Treatment of stage I lung cancer in high-risk and inoperable patients: Comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033)

Crabtree, T. D., Puri, V., Timmerman, R. D., et al. (2012) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2012.10.038 · Cited by 162 · see citing works

No Clinically Significant Changes in Pulmonary Function Following Stereotactic Body Radiation Therapy for Early- Stage Peripheral Non-Small Cell Lung Cancer: An Analysis of RTOG 0236

Stanic, S., Paulus, R., Timmerman, R. D., et al. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2013.12.050 · Cited by 160 · see citing works

Stereotactic Body Radiotherapy for Patients With Unresectable Primary Hepatocellular Carcinoma: Dose-Volumetric Parameters Predicting the Hepatic Complication

Son, S. H., Choi, B. O., Ryu, M. R., et al. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.09.009 · Cited by 141 · see citing works

Predictors of Liver Toxicity Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma

Velec, M., Haddad, C. R., Craig, T., et al. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.01.221 · Cited by 121 · see citing works

Improving Normal Tissue Complication Probability Models: The Need to Adopt a “Data-Pooling” Culture

Deasy, J. O., Bentzen, S. M., Jackson, A., et al. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.06.094 · Cited by 119 · see citing works

Radiation Dose‐Volume Effects for Liver SBRT

Miften, M. M., Vinogradskiy, Y. Y., Moiseenko, V., et al. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.12.290 · Cited by 118 · see citing works

Pediatric Normal Tissue Effects in the Clinic (PENTEC): An International Collaboration to Analyse Normal Tissue Radiation Dose–Volume Response Relationships for Paediatric Cancer Patients

Constine, L. S., Ronckers, C. M., Hua, C., et al. (2019) · Clinical Oncology · doi:10.1016/j.clon.2019.01.002 · Cited by 84 · see citing works

Clinical oncology for medical students and physicians : a multidisciplinary approach

Rubin, P., Bakemeier, R. F., & Krackov, S. K. (1991) · Cited by 77 · see citing works

Tumor control probability modeling for stereotactic body radiation therapy of early-stage lung cancer using multiple bio-physical models

Liu, F., Tai, A., Lee, P. P., et al. (2016) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2016.11.006 · Cited by 68 · see citing works

Predictors of Liver Toxicity Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma

Velec, M., Craig, T., Wang, L., et al. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.07.997 · Cited by 63 · see citing works

Modeling the Cellular Response of Lung Cancer to Radiation Therapy for a Broad Range of Fractionation Schedules

Jeong, J., Oh, J. H., Sonke, J., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-3277 · Cited by 62 · see citing works

Head and Neck Tumor Control Probability: Radiation Dose–Volume Effects in Stereotactic Body Radiation Therapy for Locally Recurrent Previously-Irradiated Head and Neck Cancer: Report of the AAPM Working Group

Vargo, J. A., Moiseenko, V., Grimm, J., et al. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.01.044 · Cited by 56 · see citing works

Dosimetric Analysis and Normal-Tissue Complication Probability Modeling of Child-Pugh Score and Albumin-Bilirubin Grade Increase After Hepatic Irradiation

Pursley, J., Naqa, I. E., Sanford, N. N., et al. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.04.027 · Cited by 53 · see citing works

Emphasis on Repair, Not Just Avoidance of Injury, Facilitates Prudent Stereotactic Ablative Radiotherapy

Kim, D. W. N., Medin, P. M., & Timmerman, R. D. (2017) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2017.04.007 · Cited by 38 · see citing works

ALERT - Adverse Late Effects of Cancer Treatment

(2013) · Medical radiology · doi:10.1007/978-3-540-72314-1 · Cited by 23 · see citing works

The statistical prognosis in radiation therapy. A study of optimal dosage in relation to physical and biologic parameters for epidermoid cancer.

Cohen, L. (1960) · PubMed · Cited by 22 · see citing works

Introduction and Clinical Overview of the DVH Risk Map

Asbell, S. O., Grimm, J., Xue, J., et al. (2015) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2015.11.005 · Cited by 16 · see citing works

Introducing the Medical Physics Dataset Article

Williamson, J. F., Das, S. K., Goodsitt, M. S., et al. (2017) · Medical Physics · doi:10.1002/mp.12003 · Cited by 15 · see citing works

The Skin Erythema for Combinations of Gamma and Roentgen Rays

Quimby, E. H., & Pack, G. T. (1929) · Radiology · doi:10.1148/13.4.306 · Cited by 13 · see citing works

ASTRO Journals’ Data Sharing Policy and Recommended Best Practices

Tegbaru, D., Braverman, L. C., Zietman, A. L., Yom, S. S., Lee, W. R., Miller, R. C., Jackson, I. L., McNutt, T., & Dekker, A. L. A. J. (2019) · Advances in Radiation Oncology · doi:10.1016/j.adro.2019.08.002 · Cited by 10 · see citing works

Application of radiobiologic principles to radiation therapy

Suit, H. D. (1968) · Cancer · doi:10.1002/1097-0142(196810)22:4 · Cited by 9 · see citing works

Introduction

Koong, A. C., & Tepper, J. E. (2017) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2017.03.005 · Cited by 6 · see citing works

Curing Metastatic Disease with Radiation Therapy: Myth or Reality?—Arguing for Reality

Rahimi, A. S., & Timmerman, R. D. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.03.009 · Cited by 3 · see citing works

Reality Check

Marks, L. B. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.11.027 · Cited by 3 · see citing works

The Emami paper 25 years later

Emami, B., Roeske, J. C., Block, A. M., et al. (2017) · Journal of Radiation Oncology · doi:10.1007/s13566-017-0295-6 · Cited by 2 · see citing works

Normal-Tissue Tolerance to Radiopharmaceutical Therapies, the Knowns and the Unknowns

Wahl, R. L., Sgouros, G., Iravani, A., Jacene, H., Pryma, D., Saboury, B., Capala, J., & Graves, S. A. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.262751 · Cited by 95 · see citing works

Practical considerations of single-fraction stereotactic ablative radiotherapy to the lung

Kang, T., Hardcastle, N., Singh, A. K., Slotman, B. J., Videtic, G. M. M., Stephans, K. L., Couñago, F., Louie, A. V., Gückenberger, M., Harden, S., et al. (2022) · Lung Cancer · doi:10.1016/j.lungcan.2022.06.014 · Cited by 7 · see citing works

Pulmonary oligometastases: Metastasectomy or stereotactic ablative radiotherapy?

Widder, J., Klinkenberg, T. J., Ubbels, J. F., et al. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.05.024 · Cited by 131 · see citing works

A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer

Murray, P., Franks, K., & Hanna, G. G. (2016) · British Journal of Radiology · doi:10.1259/bjr.20160732 · Cited by 81 · see citing works

Feasibility of split-course stereotactic ablative radiotherapy for oligometastases

Paik, E. K., Kim, M., Seo, Y.-S., et al. (2018) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyy062 · Cited by 8 · see citing works

P2.05-052 A Systematic Review and Meta-Analysis of Pneumonitis in Radically Treated NSCLC Patients: SABR. vs. Non-SABR Treatment

Hegi‐Johnson, F., Azzi, M., & D'Souza, M. I. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.11.1487